187 related articles for article (PubMed ID: 20013807)
1. Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors.
van Dongen M; Savage ND; Jordanova ES; Briaire-de Bruijn IH; Walburg KV; Ottenhoff TH; Hogendoorn PC; van der Burg SH; Gelderblom H; van Hall T
Int J Cancer; 2010 Aug; 127(4):899-909. PubMed ID: 20013807
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in therapy for gastrointestinal stromal tumors.
Maki RG
Curr Oncol Rep; 2007 May; 9(3):165-9. PubMed ID: 17430686
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumors.
Blanke CD; Huse DM
J Med Econ; 2010; 13(4):681-90. PubMed ID: 21067355
[TBL] [Abstract][Full Text] [Related]
4. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.
Rusakiewicz S; Semeraro M; Sarabi M; Desbois M; Locher C; Mendez R; Vimond N; Concha A; Garrido F; Isambert N; Chaigneau L; Le Brun-Ly V; Dubreuil P; Cremer I; Caignard A; Poirier-Colame V; Chaba K; Flament C; Halama N; Jäger D; Eggermont A; Bonvalot S; Commo F; Terrier P; Opolon P; Emile JF; Coindre JM; Kroemer G; Chaput N; Le Cesne A; Blay JY; Zitvogel L
Cancer Res; 2013 Jun; 73(12):3499-510. PubMed ID: 23592754
[TBL] [Abstract][Full Text] [Related]
5. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib.
Janeway KA; Albritton KH; Van Den Abbeele AD; D'Amato GZ; Pedrazzoli P; Siena S; Picus J; Butrynski JE; Schlemmer M; Heinrich MC; Demetri GD
Pediatr Blood Cancer; 2009 Jul; 52(7):767-71. PubMed ID: 19326424
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib for imatinib-resistant GIST.
Joensuu H
Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
[No Abstract] [Full Text] [Related]
7. [Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
[No Abstract] [Full Text] [Related]
8. The role of KIT in the management of patients with gastrointestinal stromal tumors.
Hornick JL; Fletcher CD
Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy.
Pantaleo MA; Nannini M; Di Battista M; Catena F; Biasco G
Cancer Treat Rev; 2010 Feb; 36(1):63-8. PubMed ID: 19914780
[TBL] [Abstract][Full Text] [Related]
10. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
[TBL] [Abstract][Full Text] [Related]
11. [Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear].
Ahlman H; Nilsson O; Nilsson B
Lakartidningen; 2009 Dec 9-21; 106(50-51):3424-9. PubMed ID: 20180446
[No Abstract] [Full Text] [Related]
12. New therapeutic options in gastrointestinal stromal tumors.
Stein E; Aranha O; Agulnik M
Oncology (Williston Park); 2008 Feb; 22(2):206-11; discussion 215-6, 219. PubMed ID: 18409663
[TBL] [Abstract][Full Text] [Related]
13. Hits and misses in targeting pediatric cancers.
Bernstein ML
Pediatr Blood Cancer; 2009 Jul; 52(7):751-2. PubMed ID: 19185009
[No Abstract] [Full Text] [Related]
14. Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.
Wang WL; Conley A; Reynoso D; Nolden L; Lazar AJ; George S; Trent JC
Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S15-24. PubMed ID: 21181476
[TBL] [Abstract][Full Text] [Related]
15. Second line therapies for the treatment of gastrointestinal stromal tumor.
Joensuu H
Curr Opin Oncol; 2007 Jul; 19(4):353-8. PubMed ID: 17545799
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathobiology of gastrointestinal stromal sarcomas.
Corless CL; Heinrich MC
Annu Rev Pathol; 2008; 3():557-86. PubMed ID: 18039140
[TBL] [Abstract][Full Text] [Related]
17. Current management of GISTs.
Blanke C
Clin Adv Hematol Oncol; 2010 May; 8(5):334. PubMed ID: 20551892
[No Abstract] [Full Text] [Related]
18. Perioperative treatment of gastrointestinal stromal tumors.
Fernandes Gdos S; Blanke CD; Freitas D; Guedes R; Hoff PM
Oncology (Williston Park); 2009 Jan; 23(1):54-61. PubMed ID: 19283922
[TBL] [Abstract][Full Text] [Related]
19. Prognosis, imatinib dose, and benefit of sunitinib in GIST: knowing the genotype.
Judson IR
J Clin Oncol; 2008 Nov; 26(33):5322-5. PubMed ID: 18955449
[No Abstract] [Full Text] [Related]
20. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate].
Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK
Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
